1. Pharmaceutical Sector Development in Africa: Progress to Date

   • Paul A. Lartey
   • Alexandra E. Graham
   • Margareth Ndomondo-Sigonda

   Current Opinion 19 January 2018 Pages: 1 - 11

   

2. Development of Post-Marketing Risk Management Plan Requirements: The Singapore Experience

   • Liesbet Li-Bei Tan
   • Christine Su-Ching Ho
   • Cheng-Leng Chan

   Current Opinion 26 December 2017 Pages: 13 - 20

   

3. Size and Taste Matters: Recent Progress in the Development of Age-Appropriate Medicines for Children

   • Michael Rieder

   Review Article 19 December 2017 Pages: 21 - 30

   

4. A Case Study of the Incremental Utility for Disease Identification of Natural Language Processing in Electronic Medical Records

   • Lisa S. Weiss
   • Xiaofeng Zhou
   • Robert F. Reynolds

   Short Communication 04 December 2017 Pages: 31 - 37

   

5. International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain

   • Azhar H. Alostad
   • Douglas T. Steinke
   • Ellen I. Schafheutle

   Original Research Article Open access 20 January 2018 Pages: 39 - 49

   

6. Gini Index-Based Maximum Concentration and Area Under the Curve Split Points for Analysing Adverse Event Occurrence in Bioequivalence Studies

   • Blanca L. Torres-García
   • Lucila I. Castro-Pastrana
   • Alejandro Ruíz-Argüelles

   Original Research Article 06 December 2017 Pages: 51 - 66

   

7. Forum

   Update 15 January 2018 Pages: 67 - 87

8. Major Pharmaceutical Conferences and Courses

   Update 15 January 2018 Pages: 89 - 91

9. Publisher Correction: Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development

   • Andrew J. Krentz
   • Gerardo Rodriguez-Araujo

   Publisher Correction 31 January 2018 Pages: 93 - 93